IRF4/Mum1 is expressed in a relatively large number of malignant lymphoma and reported to be associated with good prognosis for B-cell chronic lymphocytic leukemia (B-CLL) (reviewed in [37]). This evidence concerns the gene IRF4 and B-cell chronic lymphocytic leukemia.